Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignancies (Q37441525)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q56614941)
(Q71793401)
(P304) 7061-7068
(P407) (Q1860)
(P433) 22
(P478) 15
(P577) Tuesday, November 10, 2009
(P921) (Q5452194)
(P1433) (Q332253)
(P1476) "Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignancies" (language: en)
(P2093) David S Hong
Said M Sebti
Robert A Newman
Michelle A Blaskovich
Lei Ye
Robert F Gagel
Stacy Moulder
Jennifer J Wheler
Nizar M Tannir
Chaan S Ng
Steven I Sherman
Adel K El Naggar
Rabia Khan
Jon Trent
John J Wright
(P2860) (Q37158278)
(Q37368694)
(Q37121708)
(Q28282767)
(Q36263983)
(Q36615874)
(Q34412215)
(Q35989707)
(Q33363071)
(Q28238938)
(Q35158942)
(Q34376383)
(Q39987066)
(Q40428660)
(Q46308015)
(Q44820387)
(Q44567748)
(Q44012109)
(Q43615357)
(Q57579980)
(Q58289284)
(Q73445688)
(Q74628193)
(Q83195713)
(Q80249353)
other details
description scientific article

External Links